Boston, MA, United States of America

Vinny Motwani

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Epizyme, Inc.. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Vinny Motwani. Retrieved from https://idiyas.com/inventor/vinny-motwani

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Vinny Motwani: Inventor in Boston, Massachusetts.

Introduction

Vinny Motwani is an inventor based in Boston, Massachusetts. His patent work includes research into SETD2 protein inhibitors and their potential use in combination therapies.

Latest Patents

Motwani is associated with 1 patent, titled “SETD2 Inhibitors and Related Methods and Uses, Including Combination Therapies.” The disclosure describes SETD2 protein inhibitors and methods, compositions, and kits for treating diseases, disorders, or conditions. It also discusses combining a SETD2 inhibitor with other therapeutic agents, including glucocorticoid receptor agonists, immunomodulatory drugs, proteasome inhibitors, Bcl-2 inhibitors, pleiotropic pathway modulators, XPO1 inhibitors, histone deacetylase inhibitors, and EZH2 inhibitors.

Career Highlights

Motwani is associated with Epizyme, Inc. His patent work focuses on therapeutic approaches involving SETD2 protein inhibition and combinations with other classes of medicines.

Collaborations

The provided information identifies Maria Alejandra Raimondi and John W. Lampe as Motwani’s coworkers. Their inclusion here reflects the supplied association and does not specify particular joint patent contributions.

Conclusion

Vinny Motwani’s identified patent centers on SETD2 inhibitors and potential combination therapies, reflecting a focus on therapeutic innovation.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…